Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 801–900 of 1,000
Fiori-Duarte, A. T., Guarnieri, J. P. D. O., Borlot, J. R. P. D. O., Lancellotti, M., Rodrigues, R. P., Kitagawa, R. R., & Kawano, D. F. (2022) · Molecular Diversity · doi:10.1007/s11030-021-10371-8 · Cited by 5
Kamarehei, F., Saidijam, M., & Taherkhani, A. (2023) · Genomics & Informatics · doi:10.5808/gi.22072 · Cited by 5
“Previous studies have found that gastric cancer (GC) is a heterogeneous disease in which the genetic and epigenetic alterations of vital human genes associated with the cell cycle and DNA repair procedures and environmental factors mediate the occurrence and progression of the disease [6-9].”
BackgroundHu, J., Shi, X., Cao, S., Dong, X., Dai, J., & Yin, H. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113155 · Cited by 5
Species-specific components of the Helicobacter pylori Cag type IV secretion system
Bryant, K. N., Frick-Cheng, A. E., Solecki, L. E., Kroh, H. K., McDonald, W. H., Lacy, D. B., McClain, M. S., Ohi, M. D., & Cover, T. L. (2025) · Infection and Immunity · doi:10.1128/iai.00493-24 · Cited by 5
Leite, M., & Figueiredo, C. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-005-2_9 · Cited by 5
Mucito-Varela, E., Castillo-Rojas, G., Cevallos, M. A., Lozano, L., Merino, E., López-Leal, G., & López‐Vidal, Y. (2016) · Genome Announcements · doi:10.1128/genomea.01503-15 · Cited by 5
“Helicobacter pylori infection produces chronic gastritis and increases the risk of peptic ulcer, gastric cancer, and mucosaassociated lymphoid tissue (MALT) lymphoma due to the bacterial interaction between its virulence factors and the cellular components of the host (1, 2).”
BackgroundBustamante-Rengifo, J. A., Matta, A. J., Pazos, A. J., & Bravo, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i11.1980 · Cited by 5
Detection and clinical significance of DNA repair gene ERCC8 tag SNPs in gastric cancer
Lu, X., Chen, F., Liu, X., Yuan, D., Zi, Y., He, X. F., & Zhu, D. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17662 · Cited by 5
“pylori infection will develop gastric cancer (19,24).”
Yamamichi, N., Shimamoto, T., Hirano, C., Takahashi, Y., Minatsuki, C., Takeuchi, C., Takahashi, M., Sakaguchi, Y., Tsuji, Y., Niimi, K., et al. (2021) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-021-01445-z · Cited by 5
Luu, X. Q., Lee, K., Jun, J. K., Suh, M., Jung, K., Choi, I. J., & Choi, K. S. (2023) · Gastric Cancer · doi:10.1007/s10120-023-01387-0 · Cited by 5
“pylori), a significant risk factor of gastric cancer [23, 24], is commonly recommended by physicians during visits for upper GI screening.”
BackgroundModulation of innate lymphoid cells by enteric bacterial pathogens
Sah, P., & Zenewicz, L. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219072 · Cited by 6
Hirai, I., Yoshinaga, A., Kimoto, A., Sasaki, T., & Yamamoto, Y. (2010) · Current Microbiology · doi:10.1007/s00284-010-9797-9 · Cited by 5
“pylori infection is directly linked to the pathogenesis of gastric cancer [22].”
BackgroundMirkamandar, E., Shakibaie, M. R., Adeli, S., Mehrabani, M., Hayatbakhsh, M. M., & Esmailian, S. (2012) · Microbiology Research · doi:10.4081/mr.2012.e9 · Cited by 5
Li, K., DAN, Z., Nie, Y., Hu, X., Gesang, L., BIANBA, Z., Ze, Y., & Ciren, C.-M. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3924 · Cited by 5
“It is estimated that half of the world population is infected with H. pylori (10,11).”
How Can We Better Understand the Gastric Carcinogenesis of Helicobacter pylori?
Duan, Y., Dou, Y., & Xu, D. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.04.018 · Cited by 5
A Proposal for a Consolidated Structural Model of the CagY Protein of Helicobacter pylori
López-Luis, M. A., Soriano-Pérez, E. E., Parada-Fabián, J. C., Torres, J., Maldonado-Rodríguez, R., & Méndez-Tenorio, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316781 · Cited by 4
Men, C., Shan, S.-X., Ou, Z.-Y., Fu, H.-L., Wang, B., Tong, Y., Gan, Q., Meng, M., & Xi, R. (2025) · European journal of medical research · doi:10.1186/s40001-025-02792-0 · Cited by 4
“In 1994, the World Health Organization classified H. pylori as a class I carcinogen for gastric cancer [5].”
Liu, Y., Lin, Z., Yang, M., Chen, X., He, Y., Zheng, P., Li, M., & Lü, M. (2025) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000187 · Cited by 4
Wang, J., An, G., Hong, D., Zheng, Y., Zhang, H., Huang, X., & Feng, E. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.171816 · Cited by 4
Oh, H. J., Kim, C. H., Park, H.-W., & Park, B. (2025) · BMC Cancer · doi:10.1186/s12885-025-15507-9 · Cited by 6
“Emerging evidence supports the existence of H. pylori -induced carcinogenic mechanisms that bypass these intermediate lesions, including direct effects of chronic inflammation, oxidative stress, and genetic or epigenetic alterations [29, 30].”
Huang, K. K., Hagihara, T., Lian, B. S. X., Ong, Z. X., Lim, S. K., Chong, R. H. H., Srivastava, S., Kang, J. X., Lee, M. Y., Tan, A. L. K., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0778 · Cited by 6
“Hp infection is the strongest risk factor for gastric cancer (4).”
Pathirana, R. D., Capitani, N., McCrory, C., Bella, C. D., Stuart, I., Gilmore, W. J., Bitto, N. J., Tate, M. D., Johnston, E. L., Zavan, L., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2618860 · Cited by 4
Zhang, Y., Shang, Y., Li, Z., Kuang, Z., Huang, S., Ye, Q. H., Chen, J., Huang, Z., Chen, L., Li, Y., et al. (2026) · Microbial Genomics · doi:10.1099/mgen.0.001599 · Cited by 4
“Furthermore, antibiotic overuse expands the intestinal microbiome resistome, accelerating horizontal acquisition of novel resistance genes that may modulate GC through yet-uncharacterized pathways [10, 22, 23].”
Franca-Oliveira, G., Peinado, S. M., de Souza, S. M. A., Kalume, D. E., de Souza, T. L. F., Hernández‐Ledesma, B., & Martínez-Rodríguez, A. J. (2024) · Nutrients · doi:10.3390/nu16132056 · Cited by 4
“The immune response raised by H. pylori infection induces a chronic inflammatory response that is associated with gastric cancer, being the strongest risk factor for the development of this disease [10].”
BackgroundGRB7-mediated enhancement of cell malignant characteristics induced by Helicobacter pylori infection
Zhao, H., Chen, S., Bai, X., Zhang, J., Liu, S., Sun, Z., Cao, X., Wang, J., Zhang, Y., Li, B., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1469953 · Cited by 4
“…epithelial cells via T4SS, CagA can interact with a variety of signaling factors to hijack intracellular signal transduction pathways (Franco et al., 2005; Tabassam et al., 2009; Lee et al., 2010; Bronte-Tinkew et al., 2009; Polk and Peek, 2010), and further trigger the progress of carcinogenesis.”
BackgroundPreliminary investigation of the in vitro anti-Helicobacter pylori activity of Triphala
Zhu, Z., Zou, Y., Ou, L., Chen, M., Pang, Y., Li, H., Hao, Y., Su, B., Lai, Y., Zhang, L., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1438193 · Cited by 4
Zhang, P., Tao, C., Xie, H., Yang, L., Lu, Y., Xi, Y., Yao, S., Li, Y., Guo, P., & Cheng, X. (2025) · Gastric Cancer · doi:10.1007/s10120-025-01584-z · Cited by 4
“The majority of H. pylori reside in semi-permeable mucous gel layer of the stomach blanketing the apical surface of gastric mucosa epithelium [34].”
Nambiar, J., Venugopal, M., Shaji, S. K., Bose, C., Rajeev, A., Kalliadan, S., Haripriyan, J., & Nair, B. G. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42538 · Cited by 4
“For instance, the CagL adhesin of H. pylori facilitates adherence to gastric epithelial cells, triggering a signaling cascade that promotes hypergastrinemia, a major risk factor for gastric adenocarcinoma [35].”
Yan, Y., & Satoh‐Takayama, N. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05632-w · Cited by 4
“In general, ILCs are a source of cytokines very early in the course of infection and therefore play a crucial role in the immune response and activation of the downstream adaptive immune response [39].”
Toracchio, S., Caruso, R. A., Perconti, S., Rigoli, L. C., Betri, E., Neri, M., Verginelli, F., & Mariani‐Costantini, R. (2020) · Microorganisms · doi:10.3390/microorganisms8030324 · Cited by 4
Gildner, T. E., Urlacher, S. S., Nemeth, K. L., Beauregard, J. A., Nash, M. P., Zhang, A., Waimon, S., & Cepon‐Robins, T. J. (2024) · Annals of Human Biology · doi:10.1080/03014460.2024.2368851 · Cited by 4
“Infection may instead contribute to mal-nutrition risk and has been linked with severe negative health outcomes in some cases, including some gastric cancers (Blaser and Falkow 2009; Fuenmayor-Boscán et al. 2020; Polk et al. 2010).”
Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development
Halawa, M., Newman, P. M., Aderibigbe, T., & Carabetta, V. J. (2024) · iScience · doi:10.1016/j.isci.2024.111029 · Cited by 4
Miller, E. F., & Maier, R. J. (2013) · Journal of Bacteriology · doi:10.1128/jb.00587-13 · Cited by 4
High prevalence of helicobacter pylori in Basra city Southern of Iraq
Alatbee, A. H. D. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1279/1/012073 · Cited by 4
Somu, P., & Paul, S. (2020) · Heat shock proteins · doi:10.1007/7515_2020_19 · Cited by 4
OMRAN, V. H., RANAEI, M., Neamati, N., Shokri‐Shirvani, J., Hajian‐Tilaki, K., Mosapour, A., Soltanzadeh-Yamchi, M., Tourani, M., & Parsian, H. (2021) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.38.2.23 · Cited by 4
Gu, S.-Y., Cao, X., Feng, Y., Wei, Q., Liang, J., Xie, L., Liu, Y., Feng, H.-Y., & Guo, X. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104932 · Cited by 4
The Prevalence of H. Pylori cagA Gene in Patients with Gastric Ulcer
Mirzaei, S., Keshavarzi, F., & Karami, P. (2021) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.15.3.345 · Cited by 4
“This island has 31 genes out of which, 6 are coding the fourth type of secretion system and take the role in the association of the host bacteria with the pathogenicity process (1-10).”
BackgroundZhang, X., Chen, X., Guo, Y., Gao, G., Wang, D., Wu, Y., Liu, J., Liang, G., Zhao, Y., & Wu, F. (2021) · Angewandte Chemie · doi:10.1002/ange.202102059 · Cited by 4
Shimizu, M., Miyanaga, A., Seike, M., Matsuda, K., Matsumoto, M., Noro, R., Fujita, K., Mano, Y., Furuya, N., Kubota, K., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14463 · Cited by 4
“pylori and Fusobacterium nucleatum are related to a high risk of gastric cancer and poor prognosis in patients with colorectal cancer, respectively.(9,10) Received: 17 November 2021 Accepted: 25 April 2022”
BackgroundHelicobacter pyloriresults in lysis and death after exposure to water
Inamasu, Y., Ogawa, M., Saito, M., Harada, M., & Fukuda, K. (2022) · Helicobacter · doi:10.1111/hel.12921 · Cited by 4
Features of diet therapy for H. pylori associated diseases of the gastrointestinal tract
Львовна, П. Т., Minushkin, O. N., Лазебник, Л. Б., Владимирович, З. И., Kuznetsova, Y. G., & Khanferyan, R. A. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-15-46-61 · Cited by 4
Vastrad, S. J., Ritesh, G., Sowmya, S., V, Saraswathy, G. R., Augustine, D., Alzahrani, K. J., Alzahrani, F. M., Halawani, I. F., Ashi, H. M., Alshahrani, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1247399 · Cited by 5
“Amongst bacteria, it is a well-established fact that Helicobacter pylori has a signi fi cant relation with various gastrointestinal cancers (161).”
BackgroundChung, W. C., Jung, S. H., Joo, K. R., Kim, M. J., Youn, G. J., Kim, Y., Lee, J. S., Lee, H. W., Jung, J. H., & Lee, Y. K. (2013) · Gut and Liver · doi:10.5009/gnl.2013.7.6.688 · Cited by 4
“pylori has been classified as a group I carcinogen.(30,31) Several researchers hypothesized that H.”
BackgroundCell Polarity: A Key Defence Mechanism Against Infection and Cancer Cell Invasion?
Wang, Y., & Lü, X. (2015) · Springer eBooks · doi:10.1007/978-3-319-14466-5_7 · Cited by 4
“Additional pathways, including those that are mediated by the transactivation of EGFR (Polk and Peek 2010) or PI3K/ AKT (Suzuki et al.”
BackgroundAyán, C., Carral, J. M. C., Molina, A. J., Fernández‐Villa, T., & Martín, V. (2012) · European Review of Aging and Physical Activity · doi:10.1007/s11556-012-0113-5 · Cited by 4
“The Helicobacter pylori is also considered as the strongest singular risk factor for this cancer, basically mediated by the interaction of its genetic characteristics and those of the guest [39].”
BackgroundShort Course in the Microbiome
Falana, K., Knight, R. D., Martin, C. R., Goldszmid, R. S., Greathouse, K. L., Gere, J., Young, H. A., & Kuo, W. P. (2015) · Journal of Circulating Biomarkers · doi:10.5772/61257 · Cited by 4
“Late last year, investigators from Mount Sinai associated a specific combination of gut bacteria with the development of colorectal cancer [13-16].”
BackgroundMicrobiome Control in the Prevention and Early Management of Cancer
Nguewa, P., Villa, T. G., & Notario, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-28368-5_10 · Cited by 4
New Biology to New Treatment of Helicobacter pylori-Induced Gastric Cancer
Peek, R. M. (2016) · Digestive Diseases · doi:10.1159/000445231 · Cited by 4
Self-citationRojas-Rengifo, D. F., Silva, M. C. A., Guerrero, C. P. U., Vélez, V. N., Delgado, M. D. P., Aguilera-Segura, S. M., Castro, H. E., Jaramillo, C. A., & Barrios, A. F. G. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.05.016 · Cited by 4
Thiamin transport in Helicobacter pylori lacking the de novo synthesis of thiamin
Nosaka, K., Uchiyama, R., Tadano, K., Endo, Y., Hayashi, M., Konno, H., & Mimuro, H. (2019) · Microbiology · doi:10.1099/mic.0.000765 · Cited by 4
Pidkovka, N. A., Rachkevych, O., & Belkhiri, A. (2021) · Oncotarget · doi:10.18632/oncotarget.27893 · Cited by 4
“Helicobacter pylori infection in combination with genetic polymorphisms associated with a predisposition to cancer development are risk factors for gastric carcinogenesis [48].”
BackgroundAl-Matouq, J. A., Hawra, A., Alibrahim, N., Alsaffar, N., Radwan, Z. H., & Ali, M. D. (2025) · Cancers · doi:10.3390/cancers17020226 · Cited by 3
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection
Israel, A., Israel, S., Weizman, A., Ashkenazi, S., Vinker, S., Magen, E., & Merzon, E. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2545412 · Cited by 3
Liao, Y., Liu, H., Zhou, Y., & Wang, Z. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1780052 · Cited by 3
Liu, B., Li, K., Ma, R., & Zhang, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1136089 · Cited by 3
Abuduwaili, M., Takigawa, H., Yuge, R., Teshima, H., Kotachi, T., Urabe, Y., Ito, M., Sentani, K., Oue, N., Oka, S., et al. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.08.012 · Cited by 3
Macrophages in Tumor Microenvironment: From Molecular Aspects to Clinical Applications
Ammendola, M., Curcio, S., Ammerata, G., Luposella, M., Battaglia, C., Laface, C., Memeo, R., Navarra, G., Currò, G., & Ranieri, G. (2023) · Eurasian Journal of Medicine and Oncology · doi:10.14744/ejmo.2023.26480 · Cited by 3
“Although GC also originates from chronic inflammation or Helicobacter pylori in-fection,[28-29] M2 type macrophages play a crucial role in GC development, because their presence and density modify the prognosis of tumour and the resistance to treatment.”
BackgroundSirt6-Mediated Cell Death Associated with Sirt1 Suppression in Gastric Cancer
Seo, J., Ryu, S., Cheon, S. Y., Lee, S.-J., Won, S., Yim, C. D., Lee, H., Hah, Y., & Park, J. J. (2024) · Cancers · doi:10.3390/cancers16020387 · Cited by 3
“The activity of the three proteins, Sirt6, MDM2, and Sirt1, results in increased ROS production, which is responsible for an anti-tumorigenic effect, suggesting that these three molecules are potential targets for the treatment of gastric cancer.”
BackgroundTong, Y., Dang, R., Yin, Y., Men, C., & Xi, R. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107069 · Cited by 3
Genetic Basis of Gap Formation Between Migrating Helicobacter pylori Colonies in Soft Agar Assays
Elshenawi, Y., Hathroubi, S., Hu, S., Liu, X., & Ottemann, K. M. (2025) · Microorganisms · doi:10.3390/microorganisms13051087 · Cited by 3
Kim, S., Kim, B., Jung, K., Nam, G. E., Jung, W., Park, J., Han, K., & Shin, D. W. (2025) · 癌症:英文版 · doi:10.1002/cac2.70039 · Cited by 4
“Approximately ≥ 90% of Korean stomach cancer survivors were diagnosed with a non-cardia stomach cancer [60], of which major causes are infection with Helicobacter pylori ( H. pylori ) [61] as well as smoking and alcohol consumption [3].”
Wang, Y., Zhang, P., Zhou, C., Zheng, Z., Quan, Q., He, G., Zhai, H., Song, Q., Zhang, X., Li, H., et al. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07496-0 · Cited by 4
“Helicobacter pylori ( H. pylori ), a pathogenic Gram-negative bacterium, is a leading cause of chronic gastritis, peptic ulcers, and gastric cancer [1, 2].”
Association of Helicobacter Pylori Infection and Gastric Cancer
Thakur, S., Basnet, R., Bk, S. D. B., Shrestha, D., & Poudel, N. (2015) · Post-Graduate Medical Journal of NAMS · Cited by 3
Microbiome and Human Malignancies
Saha, A., & Robertson, E. S. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_1 · Cited by 4
Ye, Z.-N., Zhang, R., He, X., & Xia, H. H. (2019) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2019.00009 · Cited by 3
cagA and vacA Helicobacter pylori Pathogenicity Factors in Brazzaville, Congo
Ngoyi, E. N. O., Guilloteau, C., Bénéjat, L., Onkouo, A. M., Buissonnière, A., Sifré, E., Aloumba, G. A., Mieret, T., Bossali, F., Yala, F., et al. (2019) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2019.94018 · Cited by 3
“pylori strains with vacA alleles s1/m1/i1 are associated with an increased risk of developing severe disease, compared to positive s2/m2/i2 vacA strains [24] [38].”
BackgroundAbdelmasieh, R. Z. (2021) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2021.197457 · Cited by 3
Antimicrobial Resistance and Drug Efflux Pumps in Helicobacter
Li, J. S. Y., & Li, X.-Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_19 · Cited by 3
Functional antagonism between CagA and DLC1 in gastric cancer
Hinsenkamp, I., Köhler, J. P., Flächsenhaar, C., Hitkova, I., Meessen, S. E., Gaiser, T., Wieland, T., Weiß, C., Röcken, C., Mowat, M. R. A., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01134-x · Cited by 3
Intragastric bacterial infection and endoscopic findings in Helicobacter pylori-negative patients
Kawai, T., Kawai, Y., Akimito, Y., Hamada, M., Iwata, E., Niikura, R., Nagata, N., Yanagisawa, K., Fukuzawa, M., Itoi, T., et al. (2024) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.24-56 · Cited by 5
Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies
Lin, Z., Assaraf, Y. G., & Kwok, H. F. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10197-4 · Cited by 3
“Moreover, Helicobacter pylori (H. pylori) -associated stomach cancer has been well documented [11].”
InfluentialWhy is There a Change in Patterns of GE Cancer?
Thiagarajan, P., & Jankowski, J. A. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-31629-6_8 · Cited by 3
Identification of differentially expressed genes in gastric cancer by high density cDNA microarray
Zhang, S., Sun, H., Jin, Y., Piao, L., Jin, D., Lin, Z., & Shen, X. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.01.003 · Cited by 3
“Gastric cancer is one of the leading causes of cancer-related death in the world (1), and is the most frequent malignancy in China.”
BackgroundAmelioration of Helicobacter pylori-Induced PUD by Probiotic Lactic Acid Bacteria
Kaur, B., & Kaur, G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00067-8 · Cited by 5
Inherited Syndromes Predisposing to Inflammation and GI Cancer
Duggan, S. P., Prichard, D. O., Kirca, M., & Kelleher, D. P. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-03503-6_2 · Cited by 3
“Gastric cancer (GC) typically occurs on a background of life-long H. pylori infection associated with chronic inflammation, gastric atrophy, and achlorhydria (Argent et al. 2008; Niwa et al. 2010; Polk and Peek 2010; Waghray et al. 2010).”
BackgroundThe Microbiota: A New Player in the Etiology of Colorectal Cancer
Levy, M., Thaiss, C. A., & Elinav, E. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-013-0196-z · Cited by 3
Microbiome Analysis: Trends in Cancer Epidemiology, Challenges and Opportunities
Hebert, E. F. (2015) · International Journal of Cancer Research and Molecular Mechanisms · doi:10.16966/2381-3318.101 · Cited by 3
Retrospective study on gastrointestinal tract tumors in humans in Zaria, Kaduna State, Nigeria
Mbuk, E. U., & Amber, E. I. (2017) · Journal of Cancer Research and Experimental Oncology · doi:10.5897/jcreo2017.0146 · Cited by 4
Molina‐Castro, S., Ramírez, V., & Alpízar‐Alpízar, W. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i9.231 · Cited by 3
Rivas-Ortiz, C. I., Morales-Guerrero, S. E., Ponce‐de‐León‐Rosales, S., Gamboa‐Domínguez, A., Rangel‐Escareño, C., Uscanga-Domínguez, L. F., Aguilar‐Gutiérrez, G. R., Kershenobich, D., López‐Vidal, Y., & Castillo-Rojas, G. (2022) · Processes · doi:10.3390/pr10020196 · Cited by 3
“chronic inflammation of the gastric mucosa [6].”
BackgroundShikama, F., Bensen, S. P., Giraneza, R., Ndayisaba, P., Hategekimana, E., Rutaganda, E., Tuyizere, A., Nkakyekorera, T., Seminega, B., Ngabonziza, F., et al. (2022) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2022.1210029 · Cited by 3
Gastric Cancer and Helicobacter pylori
Amedei, A., & D’Elios, M. M. (2011) · Springer eBooks · doi:10.1007/978-94-007-2585-0_2 · Cited by 3
Pachathundikandi, S. K., Brandt, S., Madassery, J. V., & Backert, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141721 · Cited by 3
Phytosterols in the Treatment of Gastrointestinal Tract Cancers
Akkol, E., & Açıkara, Ö. B. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815049633123010013 · Cited by 3
Kong, W., Liu, W., Wang, M., Hui, W., He, H., Yu, L., & Gao, F. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70000 · Cited by 2
“In epithelial cells, H. pylori infection activates the nuclear factor-kappa B (NF-κ B) canonical pathway and the Wnt-β -catenin signaling, linking inflammation to hyperproliferation and aberrant differentiation in the gastric carcinogenesis cascade [20, 21].”
Bacteria-Based Roles in Solid Tumors: Potential for Prevention and Treatment
Huang, J., Zhang, A., Sun, J., Fu, Y., Li, W., & Wang, Y. (2025) · Pathogens · doi:10.3390/pathogens14090874 · Cited by 2
“Studies targeting genomic aberrations and dysregulated signaling pathways have long been viewed as key to tumor research [16].”
Song, Y., Zhang, S., Wang, R., Zhang, Y., Zhang, Y., Lin, H., & Wang, F. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120764 · Cited by 2
Felípez, N., Montori, S., Valero, A., Santamaría, E., Ausín, K., Peral, E., Llach, J., Delgado, P., Flórez-Díez, P., Barreiro, E., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-45298-3 · Cited by 2
“DGC is characterized by scattered poorly differentiated cells lacking glandular organization, whereas IGC follows the Correa Cascade, a progressive sequence of pathological changes from chronic gastritis to gastric adenocarcinoma 7,8 .”
Liu, W., Zhang, W., Xu, Z., Liu, W., Wang, J., Li, X., Gao, J., & Li, T. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.202523768 · Cited by 2
Wang, P., You, N., Teng, Y., Lv, Y.-P., Tian, W.-Q., Xu, J., Xie, R., Wu, J.-B., Yue, G.-Y., Cheng, P., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci193848 · Cited by 2
Diet and Upper Gastrointestinal Cancers: In Search of Dark Matter
Vaughan, T. L. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.024 · Cited by 2
Mariadi, I. K., Wibawa, I. D. N., & Wibawa, I. B. N. (2017) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/172201699-105 · Cited by 2
Synthesis of Fucose Derivatives with Thiol Motifs towards Suicide Inhibition of Helicobacter pylori
Reihill, M., Guazzelli, L., Remaut, H. K., & Oscarson, S. (2020) · Molecules · doi:10.3390/molecules25184281 · Cited by 2
Quorum Sensing Peptides and Their Interactions with the Host
Wynendaele, E., Debunne, N., Verbeke, F., Janssens, Y., Spiegeleer, A. D., & Spiegeleer, B. M. J. D. (2020) · ACS symposium series · doi:10.1021/bk-2020-1374.ch009 · Cited by 2
Is There Decreasing Prevalence of Helicobacter Pylori Infection in Patients with Dyspepsia?
Perveen, I., Saha, M., & Hasan, M. Q. (2022) · Journal of Chittagong Medical College Teachers Association · doi:10.3329/jcmcta.v33i1.67265 · Cited by 2
“Stool antigen specifically detects current ifection, whereas serological study detects both past and current infectin.(21,22) Despite this, prevalence of H.”
BackgroundKihara, T., Yamagishi, K., Imatoh, T., Ihira, H., Goto, A., Iso, H., Sawada, N., Tsugane, S., & Inoue, M. (2024) · Journal of Epidemiology · doi:10.2188/jea.je20230168 · Cited by 2
Correlation between gut microbiota dysbiosis and colorectal cancer: review
Chilimoniuk, Z., Dudziński, D., Borkowska, A., Chałupnik, A., Więsyk, P. J., Chilimoniuk, B., Gawłowicz, Ł., Grzegorzak, F., & Stasiak, K. (2024) · Quality in Sport · doi:10.12775/qs.2024.22.54326 · Cited by 2
“Research has shown that H. pylori promotes tumorigenesis through the activation of the β-catenin signaling pathway [63].”
BackgroundHemade, A., & Hallit, S. R. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002695 · Cited by 2
Shah, S. A. R., Farukh, M., Rehman, A., Shehri, Z. S. A., Alshehri, F. F., Alkhayl, F. F. A., & Noor, F. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139037 · Cited by 2
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.